Worth reading
65In focus
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
20.5
%Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPNet Sales47,234¥ millionYear on year +20.5%Progress 50.0%
Operating profit10,012¥ millionYear on year +32.0%Progress 53.7%
Ordinary income11,577¥ millionYear on year +67.1%Progress 60.7%
Net income attributable to owners of the parent8,144¥ millionYear on year +132.0%Progress 60.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥98.07
Financial position at period-end
Total assets174,551¥ million
of which net assets 122,009 ¥ millionEquity ratio 69.6%vs. prior year-end -1.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+7,620,752
Investment-18,969,432
Financials+4,741,131
Net change-6,607,549
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥40,448,681 thousand
Segment revenueDental business ¥26,962,871 thousand (YoY +14.6%), DCI business ¥12,155,168 thousand (YoY +23.6%), Surgical Business ¥3,909,019 thousand (YoY +53.4%), Machinery and Engineering ¥4,207,904 thousand (YoY +28.6%)
Segment profitDental business ¥8,961,875 thousand (YoY +11.9%), DCI business ¥674,182 thousand (YoY +913.9%), Surgical Business ¥1,474,280 thousand (YoY +20.4%), Machinery and Engineering ¥1,141,775 thousand (YoY +273.0%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥94,480 million (YoY +16.4%)
Operating profit¥18,649 million (YoY +32.4%)
Ordinary income¥19,062 million (YoY +12.6%)
Net income¥13,544 million
Revision to Earnings ForecastNot disclosed → Net Sales 94,480 / Operating profit 18,649 / Ordinary income 19,062 / Net income 13,544
Annual Dividend Forecast¥54 → Reported year-end dividend 15 / Full-year dividend before giving effect to the stock split 60（+11.1%）
Factors Behind Changes in Business Performance
Revenue increased in the Dental and Surgical businesses in all regions: Japan, North America, Europe and Asia. DCI revenue increased due to rush demand ahead of the price increase. Industrial Machinery revenue increased in Japan, North America, Europe and Asia, excluding other regions. Excluding the impact of foreign exchange, revenue still increased 12.3% year on year.
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 2 / Company name Acra Cut, Inc., Intech, Inc. / Excluded Not disclosed
Material subsequent eventsAt a meeting of the Board of Directors held on 7 August 2026, the Company resolved to conduct a 1-for-2 split of its common shares, with 30 September 2026 as the record date and 1 October 2026 as the effective date.
Impairment loss¥0 thousand
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 thousand / Extraordinary loss Loss on sale of fixed assets ¥28 thousand, Loss on Disposal of Fixed Assets ¥56,215 thousand
Depreciation and amortization¥2,110,631 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for investors and analysts)
Issued Shares at Period-End92,218,200
Treasury Shares at Period-End9,166,718
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥47,234 million (YoY +20.5%) |
| Operating profit | ¥10,012 million (YoY +32.0%) |
| Ordinary income | ¥11,577 million (YoY +67.1%) |
| Profit attributable to owners of the parent | ¥8,144 million (YoY +132.0%) |
| Net income per share | ¥98.07 |
| Equity ratio | End of the current fiscal period 69.6 / End of previous period 71 |
| Total assets | ¥174,551 million |
| Net assets | ¥122,009 million |
| Cash flows from operating activities | ¥7,620,752 thousand |
| Cash flows from investing activities | ¥-18,969,432 thousand |
| Cash flows from financing activities | ¥4,741,131 thousand |
| Cash and cash equivalents at end of period | ¥40,448,681 thousand |
| Full-year earnings forecast | Net Sales ¥94,480 million (YoY +16.4%) / Operating profit ¥18,649 million (YoY +32.4%) / Ordinary income ¥19,062 million (YoY +12.6%) / Net income ¥13,544 million |
| Revision to Earnings Forecast | Not disclosed → Net Sales 94,480 / Operating profit 18,649 / Ordinary income 19,062 / Net income 13,544 |
| Annual Dividend Forecast | ¥54 → Reported year-end dividend 15 / Full-year dividend before giving effect to the stock split 60（+11.1%） |
| Segment revenue | Dental business ¥26,962,871 thousand (YoY +14.6%), DCI business ¥12,155,168 thousand (YoY +23.6%), Surgical Business ¥3,909,019 thousand (YoY +53.4%), Machinery and Engineering ¥4,207,904 thousand (YoY +28.6%) |
| Segment profit | Dental business ¥8,961,875 thousand (YoY +11.9%), DCI business ¥674,182 thousand (YoY +913.9%), Surgical Business ¥1,474,280 thousand (YoY +20.4%), Machinery and Engineering ¥1,141,775 thousand (YoY +273.0%) |
| Depreciation and amortization | ¥2,110,631 thousand |
| Impairment loss | ¥0 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥0 thousand / Extraordinary loss Loss on sale of fixed assets ¥28 thousand, Loss on Disposal of Fixed Assets ¥56,215 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 2 / Company name Acra Cut, Inc., Intech, Inc. / Excluded Not disclosed |
| Material subsequent events | At a meeting of the Board of Directors held on 7 August 2026, the Company resolved to conduct a 1-for-2 split of its common shares, with 30 September 2026 as the record date and 1 October 2026 as the effective date. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for investors and analysts) |
| Issued Shares at Period-End | 92,218,200 |
| Treasury Shares at Period-End | 9,166,718 |
| Factors Behind Changes in Business Performance | Revenue increased in the Dental and Surgical businesses in all regions: Japan, North America, Europe and Asia. DCI revenue increased due to rush demand ahead of the price increase. Industrial Machinery revenue increased in Japan, North America, Europe and Asia, excluding other regions. Excluding the impact of foreign exchange, revenue still increased 12.3% year on year. |
Items this document does not state (5)
Operating MarginPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue grew by double digits in all businesses: Dental, DCI, Surgical and Industrial Machinery. The DCI business also benefited from rush demand ahead of the price increase. Excluding the impact of foreign exchange, revenue still increased 12.3% year on year.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.